Search Within

Doris Leithner

  1. "2023"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (2)
Groups
  1. Sloan Kettering Institute Postdocs (7)
  2. Molecular Imaging and Therapy Service (6)
  3. Radiology, Department of (6)
  4. Center for Hematologic Malignancies (5)
  5. Department of Medicine (5)
  6. Graduate Medical Education (5)

More Groups

People
  1. Heiko Schoder (5)
  2. Brandon Imber (4)
  3. Harper Hubbeling (4)
  4. Maria Palomba (4)
  5. Marius Mayerhoefer (4)
  6. Miguel-Angel Perales (4)

More People

Years
  1. 2023 (7)
Publications
  1. Blood (3)
  2. Clinical Nuclear Medicine (1)
  3. European Journal of Nuclear Medicine and Molecular Imaging (1)
  4. Hematological Oncology (1)
  5. Investigative Radiology (1)
Publishers
  1. American Society of Hematology (3)
  2. Lippincott Williams & Wilkins (2)
  3. Springer (1)
  4. Wiley Blackwell (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J. R.; Devlin, S. M.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Wills, B.; Tomas, A. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT imaging biomarkers for car-T cell therapy outcomes in large-B-cell lymphoma
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Devlin, S. M.; Mauguen, A.; Fei, T.; Zeng, S.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M.; Luttwak, E.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • ComBat harmonization for MRI radiomics: Impact on nonbinary tissue classification by machine learning
    Journal Article

    Leithner, D.; Nevin, R. B.; Gibbs, P.; Weber, M.; Otazo, R.; Vargas, H. A.; Mayerhoefer, M. E.
    Investigative Radiology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • (68)Ga-pentixafor PET/MRI for treatment response assessment in mantle cell lymphoma: Comparison between changes in lesion CXCR4 expression on PET and lesion size and diffusivity on MRI
    Journal Article

    Mayerhoefer, M. E.; Raderer, M.; Weber, M.; Lamm, W.; Kiesewetter, B.; Hacker, M.; Nics, L.; Schmitl, S.; Leithner, D.; Wester, H. J.; more...
    Clinical Nuclear Medicine (2023)

    Fulltext@MSK | Save